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SUMMARY
We report the results ofa pilot study conducted to compare the efficacy oforal prostaglandin E2
versusintravenousoxytocinininducinglabourafterloweramniotomyin20primigravidpatients
at term.
The results suggest no signiflcant differences in the performance ofeach group for the induction
to delivery interval, the mode of delivery, the Apgar score at five minutes or for third stage
abnormalities. However, theuseoforal PGE2 allows thepatientunrestricted mobility and avoids
the discomfort ofIV infusions.
INTRODUCTION
The secret of successful induction of labour lies
in replicating as accurately as possible the
physiological processes of spontaneous labour.
In the presence of a favourable cervix, a small
dose ofprostaglandin E2 (PGE2) is often enough
to induce a labour very similar to spontaneous
labour.Thismethodofinductionisalsoassociated
with a decrease in postpartum haemorrhage and
neonatal jaundice.'
Thetiming ofamniotomy iscrucial. Ifperformed
too early, before the cervix is ripe, it may lead to
complications for both mother and fetus. If left
too late, we may lose the advantage ofits uterine
sensitising influence anditsaugmentatoryeffect.
Women are requesting less interference with
labour and, in particular, as little restriction of
mobility as possible during its early stages. A
combination oforalPGE2andajudiciouslytimed
amniotomyforinductionmayallowsuchmobility
and may offer a non-invasive alternative to
intravenous oxytocin.
PATIENTS AND METHODS
Ethical committee approval of the protocol was
obtained and informed written consent obtained
fromallpatients. Twentypatients wererecruited.
They were all nulliparous at term, with an
indication for induction of labour and in the age
group 18to35years.Patientswithmajorsystemic
illness, such as severe bronchial asthma and
cardiac disease, and those with existing
contraindications totheuseofPGE2andoxytocin
were excluded from the study.
Patients were eligible for the study if, on vaginal
examination, the Bishop score was greater than
4.2
Each of the twenty patients had low amniotomy
(fore water rupture) performed under aseptic
conditions using adisposable amnihook. Noneof
the twenty patients were experiencing uterine
contractions at the time of artificial rupture of
membranes (ARM). They were then randomly
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assigned to two treatment groups. Treatment was
commenced within 30 minutes of ARM.
Group 1
Intravenous oxytocin (Syntocinon) was
administered according to the standard labour
ward regime:
Five units of Syntocinon are added to 500 ml
Hartmann's solution and an IVAC pump is used
tocontroltherateofinfusion whichiscommenced
at 5 drops per minutes. The dose is increased by
5 drops perminute every 15 minutes until regular
uterine contractions are established and are
occurring once every three minutes and lasting
for at least 40 seconds.
Group 2
PGE2 (Prostin oral tablets, Upjohn) was
administered as an initial dose of 0.5 mg tablet,
followed one hour later by 1 mg tablet, and one
hour later of 1.5 mg tablet, ifthe patient is not in
establishedlabour. Ifafterthreedosestheresponse
was poor the options were either to give another
1.5 mg oral dose or to commence intravenous
Syntocinon infusion according to the regime
prescribed above.
ASSESSMENT
The Bishop score was assessed on entry to the
study at the time of low amniotomy (Table I).
Cervical dilatation was measured at least every
two hours. The frequency, strength and duration
of uterine contractions were recorded by the
attending midwife, and the time required from
commencement of treatment till labour was
established (as defined by regular uterine
contractions occurring once every three minutes
and lasting for at least 40 seconds).
TABLE I
Pre-treatment characteristics
(standard deviations in brackets)
GROUP 1 GROUP 2
Amniotomy Amniotomy
and and
IV oxytocin oral PGE2
Gestation (weeks) 40.1 40.0
Mean (2.18) (2.16)
Bishop score 7.0 6.1
Mean (1.7) (1.9)
The duration of the first, second and third stages
of labour were recorded, together with the total
amniotomy-delivery interval and method of
delivery. Analgesicrequirements, adverseeffects
such as vomiting, abnormal cardiotocogram,
uterine hypertonus, andpresence ordevelopment
of meconium-stained liquor, were all reported.
Apgar scores at one and five minutes and the
condition ofthe baby on transfer from the labour
wardwereassessed. Allmaternalandfetaladverse
events werecarefully documented. Theattending
doctorandmidwifewereaskedfortheirsubjective
assessment and the mother was questioned as to
theacceptability ofthetreatmentshehadreceived.
The interval between amniotomy and delivery
(Table II) was greater in the oral PGE2 group,
9.8 hrs, compared with 7.5 hrs for women
receiving oxytocin, although these differences
were not statistically significant.
TABLE II
Outcome ofinduction oflabour
(Standard deviations in brackets)
GROUP 1 GROUP 2
IV Oral
oxytoicin PGE2
- Duration of first stage (hours)
(Amniotomy to full cervical dilatation)
Mean 5.73 7.98
(3.40) (3.87)
- Duration of second stage (hours)
Mean 1.63 2.62
(1.34) (12.8)
- Amniotomy-delivery interval (hours)
Mean 7.46 9.84
(3.95) (2.75)
- Mode ofdelivery
Normal delivery 7 6
Vacuum extraction 1 0
Forceps 2 2
Caesarean section 1
* 1 patient from the PGE, group was changed to IV oxytocin and had a
normal delivery.
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It was noted that patients went into established
labour within one hour of starting IV oxytocin
infusion, but not until the third dose oforal PGE2
was given, ie three hours after ARM. The
incidence of spontaneous and instrumental
deliveries was similar in the two groups. The two
Barnes-Nevilleforcepsdeliveries intheoralPGE2
group were performed because ofpersistent late
decelerations (with 60-90 seconds lag time) on
the cardiotocogram. In the IV oxytocin group,
two Barnes-Neville forceps deliveries were also
performed, the first because offetal bradycardia
and the second because of persistent late
decelerations. One vacuum extraction delivery
was also performed in this group because of
persistent left occipito-transverse position ofthe
head. Thepatient who requiredcaesarean section
(intheoralPGE2group)progressedtofullcervical
dilatation but the fetal head was grossly deflexed
in the occipito-posterior position at spines minus
one. There were no caesarean sections in the IV
oxytocin group.
Ofthose taking oral PGE2, one patient developed
severe nausea and vomiting afterthe second dose
and had to be changed to IV oxytocin. (In this
particular patient, prior to starting IV oxytocin
infusion, vaginal examination showed that the
cervix was 5-6 cm dilated and fully effaced, and
the patient had spontaneous vaginal delivery 3
hours27minutesafterstartingoxytocin infusion.)
The analgesic requirements of those receiving
oral PGE2 were similar to those who had IV
oxytocin. Two patients in the IV oxytocin group
requiredepidural analgesiaimmediately afterthe
oxytocininfusionwascommenced. Theremaining
18patientsallstartedwithintramuscularpethidine
but then requested epidural analgesia. It can be
seen from Table III that the mean neonatal
TABLE III
Neonatal outcome
GROUP GROUP
1 2
IV Oral
oxytocin PGE2
Number ofneonates 10 10
Birthweight (grams) (mean) 3256 3299
Apgar score at 1 minute (mean) 7.9 7.7
Apgar score at 5 minutes (mean) 9.3 9.2
birthweight and Apgar scores at one and five
minutes were almost the same foreach treatment
group.
The midwives evaluated both treatments as
equally effective in inducing labour.
Ofthe patients receiving oral PGE2 tablets, 90%
expressed satisfaction with this method of
induction, compared with 60% of the women in
the oxytocin group. The main reasons for
dissatisfaction were the discomfort ofthe IV line
and the restricted mobility in the first stage of
labour.
DISCUSSION
The use of oral PGE2 for the induction of labour
has previously been reported and other workers
havedrawn attentiontotheeaseofadministration
and increased patient acceptability of this route
compared with the use of intravenous infusion.
However, previous use was mostly in parous
patients withspontaneousruptureofmembranes.3
Calderet al' alsoreportedthatoralPGE2hasbeen
shown to be as effective and safe as oxytocin.
Side effects mainly in the form of nausea and
vomiting are rarely encountered unless the dose
exceeds 1 mg/hour, andthey alsoclaimedthatthe
methodismoresuccessfulinmultiparouswomen,
with few side effects seen in this group as the
majority respond to low doses.
The problem of nausea, vomiting and diarrhoea
appears to be dose-related4 and can be overcome
by applying a low dose regime such as the one
used in this study. Hauth et all reported that only
one woman vomited in a group of 50 receiving
between 0.5 and 1 mg hourly. In this study, only
onewomandevelopedseverenauseaandvomiting
in the oral PGE2 group and this occurred only
with the higher dose of I mg tablet.
The mean amniotomy-delivery interval was
shorter in the oxytocin group but this did not
reach statistical significance (probably because
womenintheoxytocingroupwentintoestablished
labourquickerthan those intheoralPGE2group).
However, themajority ofwomenintheoralPGE2
group were in established labour within three
hours of initiating treatment and progressed
satisfactorily thereafter.
A common criticism of oral administration of
oxytocic agents istheprolongeddurationofaction
which can produce problems in patients who
develop uterine hypertonus following the
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ingestion of the oxytocic agent. However, there
were no reported cases of uterine hypertonus in
this trial and, in addition, uterine hypertonus can
bereversedbyurgentadministrationofatocolytic,
either by infusion or inhalation, to reverse the
hypertonia; after an hour, normal labour can
usually be allowed to continue.6
The women considered oral PGE2 tablets to be
highlyacceptable. Themostfrequently expressed
benefits were the ability to be mobile and not
being attached to an intravenous infusion.
The midwives did not make any distinctions in
the helpfulness of either treatment; this was
probably duetoinitial lackoffamiliarity with the
oral PGE2 regimen. However, they soon adapted
to the new procedure and commented on the
simplicity of tablet administration and the fact
thatPGE2patientsenjoyedgreatermobilityduring
labour.
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